A phase-I Trial Using a Universal GM-CSF-producing and CD40L-expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-based Vaccines for Cancer Patients with Stage IV disease

Author: Dessureault Sophie   Noyes David   Lee David   Dunn Mary   Janssen William   Cantor Alan   Sotomayor Eduardo   Messina Jane   Antonia Scott  

Publisher: Springer Publishing Company

ISSN: 1068-9265

Source: Annals of Surgical Oncology, Vol.14, Iss.2, 2007-02, pp. : 869-884

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract